SK Bio GSK vaccine domestic distribution | Hankyung.com

SK Bioscience will be in charge of domestic sales and distribution of five vaccines for GSK, the world’s number one vaccine company.

SK Biosciences is a tetanus, diphtheria, pertussis vaccine’Boostrix’, meningococcal vaccine’Menbio’, hepatitis A vaccine’Habrix1440′, measles, mumps, rubella vaccine’Priolix’, cervical cancer vaccine’Servarix’ It was announced on the 6th that it has acquired five kinds of distribution and sales rights in Korea. Servarix is ​​in charge of sales in the entire domestic market including infants and toddlers. The remaining four vaccines are sold only to the adult market.

GSK transferred its sales rights to SK Bioscience to focus on the infant vaccine market. SK Bioscience plans to further expand its share of the adult vaccine market.

The domestic market size of the five vaccines that the two companies signed a joint sales contract with was 122.8 billion won last year. SK Bioscience explained that sales will increase this year as awareness of infectious diseases has increased since Corona 19.

Boostrix is ​​a vaccine suitable for adolescents and adults over the age of 10. Among tetanus, diphtheria, and whooping cough vaccines, it is the only vaccine available to the elderly over 65 years of age. In addition, Menbio is a meningococcal vaccine available to the widest range of age groups. It can be inoculated from 2 months of age. The world’s first hepatitis A vaccine HABRIX is sold in more than 100 countries, and Servarix, which can prevent cervical cancer as well as anal cancer, is sold in more than 130 countries.

SK Bioscience is also accelerating the development of its own vaccine. With the support of the Bill & Melinda Gates Foundation (BMGF), the pediatric enteritis vaccine is undergoing phase 3 clinical trials. In addition, the International Vaccine Institute (IVI) is preparing for a typhoid vaccine product license. In collaboration with Sanofi Pasteur, he is conducting phase 2 clinical trials of the next-generation pneumococcal vaccine in the United States.

Reporter Kim Woo-seop [email protected]

Ⓒ Hankyung.com prohibits unauthorized reproduction and redistribution

Source